Cargando…

Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors

Renal cancer has a global incidence and mortality of 2.2 and 1.8%, respectively. Up to 30% of these patients are intrinsically resistant to tyrosine kinase inhibitors (TKI). The National Comprehensive Cancer Network guidelines do not include any predictive factors regarding response to systemic ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Negreros-Osuna, Adrián A., Ramírez-Mendoza, Diego A., Casas-Murillo, Claudio, Guerra-Cepeda, Abraham, Hernández-Barajas, David, Elizondo-Riojas, Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647788/ https://www.ncbi.nlm.nih.gov/pubmed/36420068 http://dx.doi.org/10.3892/ol.2022.13566

Ejemplares similares

Receptor Tyrosine Kinases in Kidney Development
por: Song, Renfang, et al.
Publicado: (2011)

Tyrosine Kinase Signaling in Kidney Glomerular Podocytes
por: Hattori, Seisuke, et al.
Publicado: (2011)

Recurrent renal cell carcinoma to the breast and thigh soft tissues. A case report and review of the literature()
por: Alemán-Cabrera, Angélica Lucía, et al.
Publicado: (2020)

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors
por: Kim, Hyungjin, et al.
Publicado: (2017)

The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
por: Jamadar, Abeda, et al.
Publicado: (2021)

Efficacy of computed tomography for the prediction of colectomy and mortality in patients with clostridium difficile infection
por: Paláu-Dávila, Laura, et al.
Publicado: (2016)

Value of a breast imaging unit in the detection of breast cancer in Mexico
por: Ramírez-Galván, Yazmín A, et al.
Publicado: (2021)

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase
por: Cohen, PL, et al.
Publicado: (2004)

Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy
por: Weng, Qiaoyou, et al.
Publicado: (2021)

Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015)

Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
por: Wei, Jie, et al.
Publicado: (2021)

Acute appendicitis in Amyand’s hernia: ultrasound findings and histopathology correlation. A case report
por: Ornelas-Cortinas, Gerardo E, et al.
Publicado: (2019)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
por: Li, Chuanzhou, et al.
Publicado: (2018)

Anatomical and positional variants of the brachiocephalic trunk in a Mexican population
por: Jasso-Ramírez, Nadia Gabriela, et al.
Publicado: (2021)

Latest progress in tyrosine kinase inhibitors
por: Pospelova, Tatiana V., et al.
Publicado: (2014)

BY-kinases: Protein tyrosine kinases like no other
por: Hajredini, Fatlum, et al.
Publicado: (2022)

Tyrosine kinases in rheumatoid arthritis
por: Okamoto, Hiroshi, et al.
Publicado: (2011)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Tyrosine Kinase Inhibitors and Pregnancy
por: Abruzzese, Elisabetta, et al.
Publicado: (2014)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Tyrosine Kinase Receptors in Oncology
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2020)

Nanomedicine of tyrosine kinase inhibitors
por: Smidova, Veronika, et al.
Publicado: (2021)

Delta Radiomics Model Predicts Lesion-Level Responses to Tyrosine Kinase Inhibitors in Patients with Advanced Renal Cell Carcinoma: A Preliminary Result
por: Chen, Yuntian, et al.
Publicado: (2023)

Application of Radiomics in Prognosing Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
por: Sartages, Miriam, et al.
Publicado: (2020)

Tyrosine kinase inhibitor-induced carotid stenosis: A case report
por: Hersant, Jeanne, et al.
Publicado: (2019)

Functional Diversity of the Schistosoma mansoni Tyrosine Kinases
por: Avelar, Lívia G. A., et al.
Publicado: (2011)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
por: Gomez-Puerta, Jose A., et al.
Publicado: (2013)

Aptaligner: Automated Software for Aligning Pseudorandom DNA X-Aptamers from Next-Generation Sequencing Data
por: Lu, Emily, et al.
Publicado: (2014)

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
por: Ismail, Mohamed A., et al.
Publicado: (2021)

Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients
por: IZUMI, KOUJI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dmqq7tuj0ge018s7nu898dtel3